This pathway is heavily deregulated in cancer, either via aberrant activation of oncogenes, like PI3K itself and its downstream kinase AKT, or via the loss of tumor suppressors such as the lipid phosphatases INPP4B and PTEN. Here, PIK3CG is linked to neoplasm.